• Latest Posts

ADC Therapeutics pauses clinical trial following patient deaths

Pfizer kicks $25M into CellCentric 

Crossbow Therapeutics launches with $80M to target cancer

Immune memory research could lead to next generation of epigenetic drugs

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

NK:IO awarded £1.6M grant to develop NK cell therapy


Inhaled mRNA medicines redefine respiratory disease treatment

Existing cancer drug could be repurposed to fight certain aggressive cancers

CytoMed Therapeutics receives US patent for CAR-Gamma Delta T-cell technology

TolerogenixX expands trial and closes €12M financing

FDA approves Alzheimer’s treatment

Swedish researchers look to peptides to destroy viruses